908 Devices, Inc. (MASS)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about 908 Devices, Inc. (MASS)
Company Performance

Current Price

as of Oct 16, 2024

$3.53

P/E Ratio

N/A

Market Cap

$122.34M

Description

908 Devices, Inc. engages in the development of measurement devices for chemical and biochemical analysis. It offers products using mass spectrometry technology, an analytical technique for measuring the mass of charged molecules that is used in chemical analysis laboratories for applications, such as safety and security, food science, biotechnology, clinical diagnostics, and controlling industrial processes. Its products include desktops and handhelds. The company was founded by Kevin J. Knopp, Miller Scott, Steve Araiza, Andrew Bartfay, Michael Jobin, Christopher D. Brown, and Christopher J. Petty in 2012 and is headquartered in Boston, MA.

Metrics

Overview

  • HQBoston, MA
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerMASS
  • Price$3.53+2.62%

Trading Information

  • Market Cap$122.34M
  • Float73.51%
  • Average Daily Volume (1m)135,278
  • Average Daily Volume (3m)184,453
  • EPS-$1.15

Company

  • Revenue$52.69M
  • Rev Growth (1yr)16.15%
  • Net Income-$12.55M
  • Gross Margin51.65%
  • EBITDA Margin18.74%
  • EBITDA$2.63M
  • EV$103.63M
  • EV/Revenue1.97
  • P/EN/A
  • P/S2.28
  • P/B0.78